Cargando…
Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway
Activation of Liver X receptors (LXRs), key transcriptional regulators of glucose metabolism, normalizes glycemia and improves insulin sensitivity in rodent models with insulin resistance. However, the molecular mechanism is unclear. This study is aimed to elucidate the mechanism of LXRs-mediated li...
Autores principales: | Dong, Ying, Gao, Guirong, Fan, Hongyan, Li, Shengxian, Li, Xuhang, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409387/ https://www.ncbi.nlm.nih.gov/pubmed/25909991 http://dx.doi.org/10.1371/journal.pone.0124778 |
Ejemplares similares
-
The Liver X Receptor Agonist TO901317 Ameliorates Behavioral Deficits in Two Mouse Models of Autism
por: Cai, Yulong, et al.
Publicado: (2019) -
Liver X Receptor Agonist TO901317 Attenuates Paraquat-Induced Acute Lung Injury through Inhibition of NF-κB and JNK/p38 MAPK Signal Pathways
por: Hu, Xiao, et al.
Publicado: (2017) -
Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral hemorrhage
por: Wu, Chun-Hu, et al.
Publicado: (2016) -
Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson’s disease
por: Paterniti, Irene, et al.
Publicado: (2017) -
Calcitriol and TO-901317 Interact in Human Prostate Cancer LNCaP Cells
por: Wang, Jing-Huan, et al.
Publicado: (2008)